E2B(R3) Electronic Transmission of Individual Case Safety Reports Implementation Guide — Data Elements and Message Specification; and Appendix to the Implementation Guide — Backwards and Forwards Compatibility
Download the Final Guidance Document
The E2B(R3) document package comprises four materials. The main document is the ICSR Implementation Guidance, which includes E2B(R3) data elements and message specifications; the BFC document is an appendix to the guide provided separately. The ICH ICSR XML schema set includes all necessity schema files for creating ICH ICSR messages and ICH Acknowledgement messages plus other reference schema files. The ICH ICSR reference instance is created to be aligned with these schemas and the ICH ICSR Implementation Guidance. Although the same reference instance is included in the guidance, it is provided separately as an xml file.
Additional documents provided for information
This Information Paper explains the short history of E2B, relationship to ICH M5 and ISO IDMP standard, and ICH position on regional requirements for the exchange of ICSR messages.
This Information Paper explains the E2B(R3) Object Identifiers (OIDs).
The conversion rules between E2B(R2) and E2B(R3) messages are provided in the compatibility mapping spreadsheet. This is a base document of the BFC document above, and the conversion style-sheets are developed as implementation of these rules. The example data are not derived from the compatibility mapping spreadsheet, but present differences in E2B(R2) and E2B(R3) messages. Note that the example files do not correspond to the upgrade and down grade of each other.
If necessary, additional materials may be added during the public consultation.
Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.
August 15, 2022
This technical specifications document is to assist interested parties in electronically submitting individual case safety reports (ICSRs) (and ICSR attachments) to the Center for Drug Evaluation and...
August 2, 2022
Guidance Document August 2022 This guidance provides instructions for the electronic submission of expedited individual case safety reports (ICSRs) from investigational new drug (IND)-exempt...
May 2, 2016
On Friday, April 29th, FDA’s Center for Biologics Evaluation and Research (CBER) announced the availability of a new program supporting the submission of vaccine adverse event information. The...